Gratus Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $19M | Buy |
129,670
+7,968
| +7% | +$1.19M | 0.76% | 35 |
|
|
2024
Q1 | $19.3M | Sell |
121,702
-243
| -0.2% | -$38.7K | 0.88% | 30 |
|
|
2023
Q4 | $19.1M | Sell |
121,945
-3,065
| -2% | -$470K | 1.08% | 22 |
|
|
2023
Q3 | $19.5M | Sell |
125,010
-5,666
| -4% | -$935K | 1.32% | 19 |
|
|
2023
Q2 | $21.6M | Buy |
130,676
+20,013
| +18% | +$3.23M | 1.48% | 16 |
|
|
2023
Q1 | $17.2M | Sell |
110,663
-23,679
| -18% | -$3.82M | 1.31% | 21 |
|
|
2022
Q4 | $23.7M | Buy |
134,342
+4,134
| +3% | +$714K | 1.95% | 6 |
|
|
2022
Q3 | $21.3M | Buy |
130,208
+11,254
| +9% | +$1.9M | 2.25% | 4 |
|
|
2022
Q2 | $21.1M | Buy |
118,954
+4,897
| +4% | +$873K | 2.37% | 4 |
|
|
2022
Q1 | $20.2M | Buy |
114,057
+2,491
| +2% | +$424K | 1.94% | 12 |
|
|
2021
Q4 | $19.1M | Buy |
111,566
+7,977
| +8% | +$1.31M | 1.77% | 14 |
|
|
2021
Q3 | $16.7M | Buy |
103,589
+4,128
| +4% | +$704K | 1.8% | 10 |
|
|
2021
Q2 | $16.4M | Buy |
99,461
+7,043
| +8% | +$1.17M | 1.82% | 10 |
|
|
2021
Q1 | $15.2M | Buy |
92,418
+1,582
| +2% | +$256K | 1.82% | 10 |
|
|
2020
Q4 | $14.3M | Buy |
90,836
+4,707
| +5% | +$695K | 1.91% | 9 |
|
|
2020
Q3 | $12.8M | Buy |
86,129
+2,075
| +2% | +$307K | 2.01% | 7 |
|
|
2020
Q2 | $11.8M | Sell |
84,054
-791
| -0.9% | -$115K | 1.99% | 9 |
|
|
2020
Q1 | $11.1M | Buy |
84,845
+4,369
| +5% | +$620K | 2.08% | 7 |
|
|
2019
Q4 | $11.7M | Sell |
80,476
-566
| -0.7% | -$76.8K | 1.78% | 12 |
|
|
2019
Q3 | $10.5M | Sell |
81,042
-9,209
| -10% | -$1.21M | 1.71% | 11 |
|
|
2019
Q2 | $12.6M | Buy |
90,251
+2,048
| +2% | +$283K | 2.05% | 6 |
|
|
2019
Q1 | $12.3M | Buy |
88,203
+3,084
| +4% | +$413K | 2.07% | 7 |
|
|
2018
Q4 | $11M | Buy |
85,119
+1,241
| +1% | +$173K | 2.25% | 6 |
|
|
2018
Q3 | $11.6M | Buy |
83,878
+1,881
| +2% | +$250K | 1.59% | 7 |
|
|
2018
Q2 | $9.95M | Buy |
81,997
+76
| +0.1% | +$9.48K | 1.48% | 9 |
|
|
2018
Q1 | $10.5M | Sell |
81,921
-9,756
| -11% | -$1.32M | 1.51% | 9 |
|
|
2017
Q4 | $12.8M | Buy |
91,677
+6,379
| +7% | +$889K | 1.66% | 8 |
|
|
2017
Q3 | $11.1M | Buy |
85,298
+2,068
| +2% | +$274K | 1.54% | 10 |
|
|
2017
Q2 | $11M | Buy |
83,230
+2,000
| +2% | +$255K | 1.57% | 8 |
|
|
2017
Q1 | $10.1M | Buy |
81,230
+4,044
| +5% | +$483K | 1.46% | 9 |
|
|
2016
Q4 | $8.89M | Sell |
77,186
-22,923
| -23% | -$2.65M | 1.33% | 12 |
|
|
2016
Q3 | $11.8M | Buy |
100,109
+956
| +1% | +$116K | 1.73% | 6 |
|
|
2016
Q2 | $12M | Buy |
99,153
+29,894
| +43% | +$3.4M | 1.77% | 5 |
|
|
2016
Q1 | $7.49M | Buy |
69,259
+4,482
| +7% | +$464K | 1.64% | 6 |
|
|
2015
Q4 | $6.65M | Buy |
64,777
+11,467
| +22% | +$1.15M | 1.51% | 7 |
|
|
2015
Q3 | $4.98M | Buy |
53,310
+195
| +0.4% | +$18.9K | 1.2% | 14 |
|
|
2015
Q2 | $5.18M | Buy |
53,115
+148
| +0.3% | +$14.8K | 1.21% | 17 |
|
|
2015
Q1 | $5.33M | Buy |
52,967
+1,891
| +4% | +$192K | 1.19% | 19 |
|
|
2014
Q4 | $5.34M | Buy |
+51,076
| New | +$5.38M | 1.26% | 13 |
|
Other funds holding JNJ
Gratus Capital's JNJ Position: Q2 2024 in Review
Gratus Capital increased its Johnson & Johnson (JNJ) stake by 6.5% in Q2 2024, buying an estimated $1.19M and bringing the position to 129,670 shares worth $19M. The position accounts for 0.76% of the portfolio, ranked #35.
Gratus Capital first reported a position in JNJ in Q4 2014 and has held it in 39 quarters since. The position peaked at $23.7M in Q4 2022. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.
- Gratus Capital held 129,670 shares of Johnson & Johnson worth $19M as of Q2 2024.
- Gratus Capital bought 7,968 Johnson & Johnson shares in Q2 2024, an estimated $1.19M.
- Johnson & Johnson made up 0.76% of Gratus Capital's portfolio in Q2 2024, its #35 holding.
- Gratus Capital first reported a position in Johnson & Johnson in Q4 2014 and has held it in 39 quarters since.
- Gratus Capital's Johnson & Johnson position peaked at $23.7M in Q4 2022.
- 3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.
Based on Gratus Capital's 13F filing for Q2 2024, filed 25 Jul 2024.